3-Chloro-2-(chloromethyl)-5-(trifluoromethyl)pyridine

Catalog No. :
ACIZVK398
CAS No. :
175277-52-8
Molecular Formula :
C7H4Cl2F3N
Molecular Weight :
230.02

IUPAC Name:3-chloro-2-(chloromethyl)-5-(trifluoromethyl)pyridine

3-Chloro-2-(chloromethyl)-5-(trifluoromethyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$166.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-2-(chloromethyl)-5-(trifluoromethyl)pyridine
IUPAC Name3-chloro-2-(chloromethyl)-5-(trifluoromethyl)pyridine
MDL No.MFCD00173852
Molecular FormulaC7H4Cl2F3N
Molecular Weight230.02
SMILESFC(F)(F)C1=CN=C(CCl)C(Cl)=C1
InChI KeyNUSXEDNPFNWFDQ-UHFFFAOYSA-N
Synonym3-CHLORO-2-(CHLOROMETHYL)-5-(TRIFLUOROMETHYL)PYRIDINE;3-Chloro-2-(chloromethyl)-5-(trifluoromethyl)-;3-Chloro-2-(chloromethyl)-5-(trifluoromethyl)pyridine 97%;3-Chloro-2-(chloromethyl)-5-(trifluoromethyl)pyridine97%;Pyridine,3-chloro-2-(chloromethyl)-5-(trifluoromethyl)-;3-Chloro-2-chloromethyl-5-(trifluoromethyl)pyridine (research chemical).
CAS No.175277-52-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACIZVK398 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIZVK398 route product structure diagram
    ACIZVK398175277-52-8
Inquiry

2. ACIZVK398 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAIWR254 route compound structure diagram
    ACAIWR2541033463-31-8 In Stock
  4. Then
  5. ACIZVK398 route product structure diagram
    ACIZVK398175277-52-8
Inquiry

Comments (0)